Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 813-358-5 | CAS number: 4886-26-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 20 February 2018 - 08 June 2018 (Draft Report)
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- 1-phenyl-3-(phenylsulfamoyl)urea
- EC Number:
- 813-358-5
- Cas Number:
- 4886-26-4
- Molecular formula:
- C13H13N3O3S
- IUPAC Name:
- 1-phenyl-3-(phenylsulfamoyl)urea
- Test material form:
- solid: particulate/powder
- Details on test material:
- - State of aggregation:
- Particle size distribution:
- Mass median aerodynamic diameter (MMAD):
- Geometric standard deviation (GSD):
- Shape of particles:
- Surface area of particles:
- Crystal structure:
- Coating:
- Surface properties:
- Density:
- Moisture content:
- Residual solvent:
- Activation:
- Stabilisation:
- Other:
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Envigo
San Pietro al Natisone (UD)
Zona Industriale Azzida, 57,
33049 Italy
- Females (if applicable) nulliparous and non-pregnant: yes
- Microbiological status of animals, when known: SPF, without further details given
- Age at study initiation: 9 weeks
- Weight at study initiation: 20.0 -23.1 g
- Housing: individual
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 13 days
- Indication of any skin lesions: none reported
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 16.2 - 26.2 °C
- Humidity (%): 23 - 86 %
- Air changes (per hr): 15-20 /h
- Photoperiod (hrs dark / hrs light): 12 / 12
Study design: in vivo (LLNA)
- Vehicle:
- other: Dioxane:olive oil mixture (4:1 (v/v))
- Concentration:
- 5 %
10%
25 % - No. of animals per dose:
- 4
- Details on study design:
- PRE-SCREEN TESTS:
The Preliminary Irritation/Toxicity Test was started according to the Study Plan on CBA/CaOlaHsd mice using two doses (2 animals/dose) per vehicle with the concentrations of 25 % and 10% (w/v) in 4:1 (v/v) dioxane:olive oil), or 4:1 (v/v) diglyme:olive oil. The preliminary experiment was conducted in a similar experimental manner to the main study, but it was terminated on Day 6 and the radioactive proliferation assay was not performed. The maximum concentration of 25% was justified by trial formulation and Sponsor’s information.
In the Preliminary Irritation / Toxicity Test, all mice were observed daily for any clinical signs of systemic toxicity or local irritation at the application site. Both ears of each mouse were observed for erythema and scored. Ear thickness was also measured using a thickness gauge on Day 1 (pre-dose), Day 3 (approximately 48 hours after the first dose) and Day 6. Additional quantification of the ear thickness was performed by ear punch weight determination after the euthanasia of the experimental animals.
The comparison of the two vehicles showed that the 4:1 dioxane:olive oil (v/v) gave a better positive control result than the 4:1 (v/v) diglyme:olive oil. Also, in this study, the formulations with 4:1 (v/v) diglyme:olive oil gave higher value of ear thickness than 4:1 dioxane:olive oil (v/v).
Dioxane:olive oil mixture (4:1 (v/v)) was selected by the Sponsor for vehicle of the main test. Based on these results of the preliminary experiment, 25% (w/v) dose was selected as top dose for the main test
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method:
PROLIFERATION ASSAY with 3HTdR according to Guideline
- Criteria used to consider a positive response:
The test item is regarded as a sensitizer if both of the following criteria are fulfilled:
- That exposure to at least one concentration of the test item resulted in an incorporation of 3HTdR at least 3-fold or greater than recorded in control mice, as indicated by the stimulation index.
- The data are compatible with a conventional dose response, although allowance must be made (especially at high topical concentrations) for either local toxicity or immunological suppression.
TREATMENT PREPARATION AND ADMINISTRATION:
Injection of Tritiated Thymidine (3HTdR)
On Day 6, animals were taken to the radioactive suite and each mouse was intravenously injected via the tail vein with 250 L of sterile PBS (phosphate buffered saline) containing approximately 20 Ci of 3HTdR using a gauge 25G x 1" hypodermic needle with 1 mL sterile syringe. Once injected, the mice were left for 5 hours (± 30 minutes). - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Mean was calculated over the 4 replicates per dose.
Results and discussion
- Positive control results:
- The result of the positive control substance -Hexylcinnamaldehyde (HCA) dissolved in the same vehicle (DOO, 4:1 dioxane:olive oil) was used to demonstrate the appropriate performance of the assay [1]. The positive control substance was examined at a concentration of 25 % in the relevant vehicle using CBA/CaOlaHsd mice.
No mortality, cutaneous reactions or signs of toxicity were observed for the positive control substance in the study. A lymphoproliferative response (stimulation index value of 10.5) of HCA observed in the study was in line with historical control data of the positive control substance using other vehicles and also the results observed in the vehicle compatibility study
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- SI
- Value:
- 1.5
- Test group / Remarks:
- 25% in 4:1 dioxane:olive oil (v/v)
- Key result
- Parameter:
- SI
- Value:
- 2.2
- Test group / Remarks:
- 10% in 4:1 dioxane:olive oil (v/v)
- Key result
- Parameter:
- SI
- Value:
- 1.7
- Test group / Remarks:
- 5% in 4:1 dioxane:olive oil (v/v)
- Cellular proliferation data / Observations:
- No mortality or signs of systemic toxicity were observed during the study.
Test item precipitate was observed in 4 out of 4 animals in the 25% (w/v) dose group on Days 1, 2 and 3; and in 1 out of 4 animals in the 10% (w/v) dose groups on Days 1 and 2. No test item precipitate was observed on the ears of any other animals.
Slight decrease was observed in individual body weight in all treatment and positive control groups. However, as marked body weight loss (>5%) was observed in one animal of the negative control group, this fact was considered to have no toxicological relevance.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In conclusion, under the conditions of the present assay, N-phenyl-N'-[(phenylamino)sulfonyl]urea did not show a sensitisation potential (non-sensitizer) in the Local Lymph Node Assay.
- Executive summary:
The aim of this study was to determine the skin sensitisation potential and potency of N-phenyl-N'-[(phenylamino)sulfonyl]urea following dermal exposure in mice. The study was performed with vertebrate animals as no full regulatoryin vitroalternative is available. The minimum number of animals was used, in accordance to the regulatory guidelines for animal welfare.
The object of this study is to determine the skin sensitisation potential and potency of the test item following dermal exposure. The study has been performed with vertebrate animals as the applied regulatoryin vitro alternative tests* showed inconclusive/equivocal results. Therefore, an in vivo study has been run to provide reliable information about the skin sensitisation potential and potency of the test item for regulatory acceptance.
*IMPORTANT NOTE: With Commission Regulation (EU) 2016/1688 adopted on the 20th September 2016, the testing strategy for the assessment of the skin sensitization potential of a new substance now includes mandatory in vitro testing before any in vivo testing can be carried out, if the in vitro tests are technically feasible. This applies to all substances to be tested for EU REACH and CLP, but not for other regulatory purposes.
The recommended vehicles by OECD 429 were considered inappropriate by the Sponsor due to stability reasons. Therefore, based on literature and available stability information of the Sponsor, the compatibility of two alternative vehicles (4:1 (v/v) dioxane:olive oil and 4:1 (v/v) diglyme:olive oil) were tested in a previous vehicle compatibility study (Citoxlab study code 17/223-037EEV). Both of them were confirmed as acceptable vehicles in the LLNA by use of positive control testing. The 25 % (w/v) formulations were the highest feasible concentration for both vehicles which were suitable for the test. The formulations appeared to be opalescent solution, by visual examination.
As requested by the Sponsor, both vehicles were used in the Preliminary Irritation/Toxicity Test. The Preliminary Irritation/Toxicity Test was performed in CBA/CaOlaHsd mice using two doses per vehicle (2 animals/dose): 25, 10 % (w/v) in 4:1 dioxane:olive oil (v/v) and 25, 10 % (w/v) in 4:1 diglyme:olive oil (v/v).
Based on the Preliminary Compatibility Test, on the observations recorded in the preliminary test, scientific advice from Citoxlab Hungary Ltd. and in agreement with the Sponsor, 25% (w/v)in 4:1 dioxane:olive oil (v/v) mixture (abbreviated as DOO)was selected as top dose for the main test.
In the main assay,twenty-five female CBA/CaOlaHsd mice were allocated to five groups of four animals each:
- three groups received N-phenyl-N'-[(phenylamino)sulfonyl]urea (formulated inDOO)at 25, 10 and 5 % (w/v) concentrations respectively,
- the negative control group received the vehicle (DOO) only,
- the positive control group received 25 % (w/v)a-Hexylcinnamaldehyde (HCA, dissolved inDOO).
The test item solutions were applied on the dorsal surface of ears of experimental animals (25 µL/ear) for three consecutive days (Days 1, 2 and 3). There was no treatment on Days 4, 5 and 6. The cell proliferation in the local lymph nodes was assessed by measuring disintegrations per minutes after incorporation of tritiated methyl thymidine (3HTdR) and the values obtained were used to calculate stimulation indices (SI) in comparison with the control group.
No mortality or signs of systemic toxicity were observed during the study. Test item precipitate was observed in 4 out of 4 animals in the 25 % (w/v) dose group on Days 1, 2 and 3; and 1 out of 4 animals in the 10 % (w/v) dose group on Days 1 and 2. No test item precipitation was observed on the ears of any other animals. No test item related effect was observed on body weight.
The observed stimulation index values were 1.5, 2.2 and 1.7 at concentrations of 25, 10 and 5 % (w/v), respectively.
The result of the positive control substance a-Hexylcinnamaldehyde dissolved in the same vehicle (4:1 (v/v) dioxane:olive oil) was used to demonstrate the appropriate performance of the assay and to justify the use of this non-standard vehicle. The lymphoproliferative response was in line with historical positive control data for the positive control chemical, this result confirmed the validity of the assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.